                         SEQUENCE LISTING

<110>  Hadasit Medical Research Services and Development Ltd.
 
<120>  CIRCULATING miR-10b AND/OR miR-21 AS MARKERS FOR RESPONSE TO 
       ANTIANGIOGENIC TREATMENT IN BRAIN CANCER PATIENTS

<130>  HDST042PCT

<150>  US 62/103602
<151>  2015-01-15

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  22
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  From human

<400>  1
uagcuuauca gacugauguu ga                                                22


<210>  2
<211>  23
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  From human

<400>  2
uacccuguag aaccgaauuu gug                                               23


<210>  3
<211>  106
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  From human

<400>  3
gugcucgcuu cggcagcaca uauacuaaaa uuggaacgau acagagaaga uuagcauggc       60

cccugcgcaa ggaugacacg caaauucgug aagcguucca uauuuu                     106


<210>  4
<211>  22
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  From human

<400>  4
cugugcgugu gacagcggcu ga                                                22


<210>  5
<211>  22
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  From human

<400>  5
uagguaguuu ccuguuguug gg                                                22


